No.143:Announcement of Cessation -Salmeterol xinafoate/ Fluticasone propionate

State Food and Drug Administration

Announcement of Administrative Protection for Pharmaceuticals



Announcement No.143 (Announcement of Cessation)

Country:                           Belgium

Applicant:                         Glaxo Wellcome Belgium S.A.

Name of the Pharmaceuticals:

        Generic Name:      Salmeterol xinafoate/Fluticasone propionate Inhalation Aerosol

Brand Name:         Seretide Evohaler

Authorization No.:        B-BE02041704

Authorization Date:      April  17, 2002


This is to announce that the administrative protection to the aforementioned pharmaceuticals granted on April  17, 2002in China has expired on October 17, 2009.



Date:   October 23, 2009.